219 related articles for article (PubMed ID: 32592111)
1. Drug dosing during pregnancy-opportunities for physiologically based pharmacokinetic models.
Abduljalil K; Badhan RKS
J Pharmacokinet Pharmacodyn; 2020 Aug; 47(4):319-340. PubMed ID: 32592111
[TBL] [Abstract][Full Text] [Related]
2. Prediction of maternal pharmacokinetics using physiologically based pharmacokinetic models: assessing the impact of the longitudinal changes in the activity of CYP1A2, CYP2D6 and CYP3A4 enzymes during pregnancy.
Abduljalil K; Pansari A; Jamei M
J Pharmacokinet Pharmacodyn; 2020 Aug; 47(4):361-383. PubMed ID: 32840724
[TBL] [Abstract][Full Text] [Related]
3. Anatomical and physiological alterations of pregnancy.
Kazma JM; van den Anker J; Allegaert K; Dallmann A; Ahmadzia HK
J Pharmacokinet Pharmacodyn; 2020 Aug; 47(4):271-285. PubMed ID: 32026239
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of drugs in pregnancy.
Feghali M; Venkataramanan R; Caritis S
Semin Perinatol; 2015 Nov; 39(7):512-9. PubMed ID: 26452316
[TBL] [Abstract][Full Text] [Related]
5. Development of a Novel Maternal-Fetal Physiologically Based Pharmacokinetic Model II: Verification of the model for passive placental permeability drugs.
Zhang Z; Unadkat JD
Drug Metab Dispos; 2017 Aug; 45(8):939-946. PubMed ID: 28049636
[TBL] [Abstract][Full Text] [Related]
6. Optimization of the betamethasone and dexamethasone dosing regimen during pregnancy: a combined placenta perfusion and pregnancy physiologically based pharmacokinetic modeling approach.
Van Der Heijden JEM; Van Hove H; Van Elst NM; Van Den Broek P; Van Drongelen J; Scheepers HCJ; De Wildt SN; Greupink R
Am J Obstet Gynecol; 2024 May; ():. PubMed ID: 38763343
[TBL] [Abstract][Full Text] [Related]
7. Development of a Novel Maternal-Fetal Physiologically Based Pharmacokinetic Model I: Insights into Factors that Determine Fetal Drug Exposure through Simulations and Sensitivity Analyses.
Zhang Z; Imperial MZ; Patilea-Vrana GI; Wedagedera J; Gaohua L; Unadkat JD
Drug Metab Dispos; 2017 Aug; 45(8):920-938. PubMed ID: 28588050
[TBL] [Abstract][Full Text] [Related]
8. Prediction of Maternal and Fetoplacental Concentrations of Cefazolin, Cefuroxime, and Amoxicillin during Pregnancy Using Bottom-Up Physiologically Based Pharmacokinetic Models.
Abduljalil K; Ning J; Pansari A; Pan X; Jamei M
Drug Metab Dispos; 2022 Apr; 50(4):386-400. PubMed ID: 35046066
[TBL] [Abstract][Full Text] [Related]
9. Application of physiologically based pharmacokinetic modeling for sertraline dosing recommendations in pregnancy.
George B; Lumen A; Nguyen C; Wesley B; Wang J; Beitz J; Crentsil V
NPJ Syst Biol Appl; 2020 Nov; 6(1):36. PubMed ID: 33159093
[TBL] [Abstract][Full Text] [Related]
10. Drug Dosing in Pregnant Women: Challenges and Opportunities in Using Physiologically Based Pharmacokinetic Modeling and Simulations.
Ke AB; Greupink R; Abduljalil K
CPT Pharmacometrics Syst Pharmacol; 2018 Feb; 7(2):103-110. PubMed ID: 29349870
[TBL] [Abstract][Full Text] [Related]
11. Physiologically based pharmacokinetic model of midazolam disposition during pregnancy.
Andrew MA; Hebert MF; Vicini P
Annu Int Conf IEEE Eng Med Biol Soc; 2008; 2008():5454-7. PubMed ID: 19163951
[TBL] [Abstract][Full Text] [Related]
12. Physiologically Based Pharmacokinetic Models to Predict Maternal Pharmacokinetics and Fetal Exposure to Emtricitabine and Acyclovir.
Liu XI; Momper JD; Rakhmanina N; van den Anker JN; Green DJ; Burckart GJ; Best BM; Mirochnick M; Capparelli EV; Dallmann A
J Clin Pharmacol; 2020 Feb; 60(2):240-255. PubMed ID: 31489678
[TBL] [Abstract][Full Text] [Related]
13. Prediction of Maternal and Fetal Acyclovir, Emtricitabine, Lamivudine, and Metformin Concentrations during Pregnancy Using a Physiologically Based Pharmacokinetic Modeling Approach.
Abduljalil K; Pansari A; Ning J; Jamei M
Clin Pharmacokinet; 2022 May; 61(5):725-748. PubMed ID: 35067869
[TBL] [Abstract][Full Text] [Related]
14. Variation of drug kinetics in pregnancy.
Pavek P; Ceckova M; Staud F
Curr Drug Metab; 2009 Jun; 10(5):520-9. PubMed ID: 19689248
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic Drug Monitoring in Pregnant Patients.
Johnson-Davis KL; Doyle K
Ther Drug Monit; 2020 Apr; 42(2):172-180. PubMed ID: 31609886
[TBL] [Abstract][Full Text] [Related]
16. Model-Informed Dose Optimization in Pregnancy.
Chaphekar N; Caritis S; Venkataramanan R
J Clin Pharmacol; 2020 Oct; 60 Suppl 1():S63-S76. PubMed ID: 33205432
[TBL] [Abstract][Full Text] [Related]
17. Optimization of Drugs Pharmacotherapy During Pregnancy Using Physiologically Based Pharmacokinetic Models - An Update.
Alsmadi MM; Idkaidek N
Curr Drug Metab; 2018; 19(12):972-978. PubMed ID: 29962340
[TBL] [Abstract][Full Text] [Related]
18. Physiologically Based Pharmacokinetic modelling of drugs in pregnancy: A mini-review on availability and limitations.
Berezowska M; Sharma P; Pilla Reddy V; Coppola P
Fundam Clin Pharmacol; 2024 Jun; 38(3):402-409. PubMed ID: 37968879
[TBL] [Abstract][Full Text] [Related]
19. Pregnancy- Associated Changes in Pharmacokinetics and their Clinical Implications.
Koren G; Pariente G
Pharm Res; 2018 Feb; 35(3):61. PubMed ID: 29435666
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic monitoring of antiepileptic drugs during pregnancy and in the postpartum period: is it useful?
Adab N
CNS Drugs; 2006; 20(10):791-800. PubMed ID: 16999450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
